Ligand validation:2VUW

5ID: (2R,3R,4S,5R)-2-(4-AMINO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL

5ID is a Ligand Of Interest in 2VUW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VUW_5ID_A_1800	91%	10%	0.108	0.994	1.35	2.9	3	7	1	0	100%	0.9785
6G39_5ID_A_802	98%	68%	0.063	0.988	0.58	0.66	-	-	0	0	100%	0.35
6G3A_5ID_A_805	97%	59%	0.076	0.989	0.66	0.91	-	-	2	0	100%	0.965
3IQ7_5ID_A_799	93%	26%	0.097	0.991	0.97	2.02	1	5	1	0	100%	0.985
4OUC_5ID_A_808	89%	28%	0.106	0.985	1.17	1.7	2	4	1	0	100%	0.6
5OD2_5ID_A_502	99%	1%	0.058	0.992	4.77	3.66	11	8	0	0	100%	1
2C47_5ID_D_1300	94%	25%	0.083	0.982	1.49	1.54	2	5	0	0	100%	1
2ZOQ_5ID_B_382	91%	22%	0.094	0.982	1.35	1.86	2	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.